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Bone is one of the most common sites of cancer metastasis, as its fertile
microenvironment attracts tumor cells. The unique mechanical properties of bone
extracellular matrix (ECM), mainly composed of hydroxyapatite (HA) affect a number
of cellular responses in the tumor microenvironment (TME) such as proliferation,
migration, viability, and morphology, as well as angiogenic activity, which is related to
bone metastasis. In this study, we engineered a bone-mimetic microenvironment to
investigate the interactions between the TME and HA using a microfluidic platform
designed for culturing tumor cells in 3D bone-mimetic composite of HA and fibrin. We
developed a bone metastasis TME model from colorectal cancer (SW620) and gastric
cancer (MKN74) cells, which has very poor prognosis but rarely been investigated.
The microfluidic platform enabled straightforward formation of 3D TME composed
the hydrogel and multiple cell types. This facilitated monitoring of the effect of HA
concentration and culture time on the TME. In 3D bone mimicking culture, we found that
HA rich microenvironment affects cell viability, proliferation and cancer cell cytoplasmic
volume in a manner dependent on the different metastatic cancer cell types and culture
duration indicating the spatial heterogeneity (different origin of metastatic cancer) and
temporal heterogeneity (growth time of cancer) of TME. We also found that both SW620
and MKN72 cells exhibited significantly reduced migration at higher HA concentration
in our platform indicating inhibitory effect of HA in both cancer cells migration. Next, we
quantitatively analyzed angiogenic sprouts induced by paracrine factors that secreted
by TME and showed paracrine signals from tumor and stromal cell with a high HA
concentration resulted in the formation of fewer sprouts. Finally we reconstituted
vascularized TME allowing direct interaction between angiogenic sprouts and
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tumor-stroma microspheroids in a bone-mimicking microenvironment composing a
tunable HA/fibrin composite. Our multifarious approach could be applied to drug
screening and mechanistic studies of the metastasis, growth, and progression of
bone tumors.
Keywords: tumor microenvironment, vascularized tumor, cancer metastasis, angiogenesis, hydroxyapatite, fibrin
matrix, microfluidic platform
INTRODUCTION
Cancer metastasis, a complex phenomenon in which cancer
cells spread to new organs, is one of the greatest challenges in
cancer research. Metastasis is influenced by surrounding stromal
cells and the extracellular matrix (ECM), as well as tumor
cells (Coleman, 2001). Tumor angiogenesis also contributes to
cancer metastasis (Weis and Cheresh, 2011; Bielenberg and
Zetter, 2015). Therefore, tumor angiogenesis and the interactions
between cancer cells and the ECM influence the invasion and
metastasis of cancer cells (Ma et al., 2008; Gill and West,
2014). To investigate the complex interactions in the tumor
microenvironment (TME), previous studies have constructed in
vitro TME models (Wang et al., 2014; Ahn et al., 2017; Chung
et al., 2017), which led to the development of a drug/nanoparticle
delivery test system for cancer therapy (Ahn et al., 2018a; Du
et al., 2018; Sei et al., 2018).
Bone is one of the most common locations of cancer cell
metastasis. Aggressive tumor cells are prone to be extremely
metastatic in the fertile bone environment (Coleman, 2001),
becoming a frequent cause of morbidity and mortality in patients
with advanced cancer (Coleman, 2001; Pathi et al., 2010). The
prognosis of patients with bone metastasis is very poor, with
a 5-year survival rate of <5%. Most patients at stage 3 or 4
have bone metastasis (>51% for colorectal cancer and >61% for
gastric cancer) at the initial diagnosis of colorectal and gastric
cancer (Ahn et al., 2011; Baek et al., 2016). To recapitulate
bone metastasis from colorectal and gastric cancer, we used
the highly metastatic colon cancer cell line SW620 (from a
lymph node metastasis) and the gastric cancer cell line MKN74
(from a liver metastasis). The prognosis of patients with bone
metastasis from colorectal and gastric cancer is poor because
of the advanced stage of the disease and largely unknown
metastatic behavior in the bone TME (Sundermeyer et al., 2005).
The bone microenvironment consists of the inorganic mineral
hydroxyapatite [Ca10(PO4)6(OH)2] (HA), with a thickness of
1.5–4.5 nm. HA is located within mineralized fibrils and has
high stiffness, toughness, and biocompatibility (Lai et al., 2014).
Thus, the addition of HA nanoparticles to the ECM enables
recapitulation of the physiological environment in vitro (Pathi
et al., 2010, 2011; Zhu et al., 2016b). Moreover, due to the unique
properties of HA, synthetic HA nanoparticles have been used for
biomedical applications (Hanawa, 2012) to promote cell growth
and inhibit apoptosis (Shi et al., 2009).
The effects of bone mineral components on tumor cells
have been investigated. In addition to enhancing normal bone
formation, the HA-mineralized microenvironment mediates
bone cancer metastasis and, consequently, secondary tumor
formation due to increased cellular adhesion and proliferation,
and anti-inflammatory activity (Pathi et al., 2010, 2011; Pilmane
et al., 2011; Zhu et al., 2016b). Although HA nanoparticles exert
minimal effects on normal cells, they inhibit the proliferation
of tumor cells, such as breast cancer, colorectal cancer, gastric
cancer, and hepatoma cells (Liu et al., 2003; Yin et al., 2006; Chen
et al., 2007; Alépée et al., 2010; Meena et al., 2012; Dey et al.,
2014; Han et al., 2014). Furthermore, the inhibitory effect of HA
nanoparticles on cancer cells is dose-dependent (Han et al., 2014).
However, the cause of metastasis in the bone microstructure
is unclear.
The effects of the mechanical properties of the ECM on
cells can be analyzed by observing cellular mobility in an
HA/hydrogel composite. For example, the effect of an increased
concentration of HA in the HA/collagen/fibrin composite on
periosteal and endothelial cells (ECs) has been examined in
vivo and in vitro (Zhang et al., 2006; Rao et al., 2014).
Moreover, bone metastasis of breast and prostate cancer cells
was recapitulated in vitro using an HA-containing scaffold
(Lin et al., 2001; Meena et al., 2012). However, rheological
analysis of HA-containing ECM, which affects cellular mobility,
is lacking. Furthermore, an in vitro model of cancer metastasis
in an osseous microenvironment focused on breast and prostate
cancer (Lin et al., 2001; Pathi et al., 2011; Zhu et al., 2016a).
Microfluidic devices have been developed to investigate breast
cancer metastasis and cancer extravasation in an osteocell
microenvironment (Bersini et al., 2014). Compared to breast and
prostate cancer, bone metastasis of gastric cancer (Yoshikawa
and Kitaoka, 1983; Kammori et al., 2001; Ahn et al., 2011) and
colon cancer (Katoh et al., 1995; Sundermeyer et al., 2005) rarely
delays diagnosis.
In this study, we analyzed the gel rheology of an HA/fibrin
composite to assess the influence of the mechanical properties
of the ECM on the TME (Figure 1). We incorporated
colorectal cancer (SW620) and gastric cancer (MKN74) cells
within a bone-mimicking microfluidic platform consisting
of an HA/fibrin composite and investigated their viability,
morphology, proliferation, and migration. Fibroblasts were co-
cultured for the bonemicroenvironment instead of osteoblasts, as
the fibroblasts within the bonematrix are genetically analogous to
osteoblasts (Ducy et al., 2000). Furthermore, tumor angiogenesis,
a key factor in cancer metastasis, was investigated using our
platform by assessing sprouting characteristics and secreted
factors. Moreover, the vascularized TME was reconstructed in
the bone-mimicking matrix, which included three-dimensional
(3D) tumor spheroids that resembled the TME in bone.
By reconstituting bone microstructure with the TME in a
microfluidic platform and analyzing its rheological properties of
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FIGURE 1 | Scheme for reconstruction of tumor microenvironment (TME) in bone-mimicking extracellular matrix (ECM) composite in the microfluidic chip. (A) The
composites include cells composing of tumor microenvironment such as cancer cells, endothelial cells and fibroblasts as well as hydroxyapatite (HA) mineral
component consisting of bone matrix. Using this microfluidic platform, we analyzed cancer viability, proliferation, cytoplasmic volume, migration, cancer induced
angiogenesis, and tumor spheroid induced angiogenesis. (B) Configuration of microchannels of the microfluidic platform indicating their dimensions and a photograph
of a microfluidic chip for bone-mimicking TME.
the microstructure, we evaluated the relationship between the
properties of the ECM and tumor angiogenesis and metastasis.
RESULTS AND DISCUSSION
Morphology of the HA/Fibrin Composite
To recapitulate the mineralized bone TME, which comprises
mainly a stiff ECM and calcium phosphate (which provide
hardness and rigidity), we incorporated HA into the fibrin
ECM. We have reported previously on various structures
consisting of pure fibrin (0% HA) and fibrin with 0.05, 0.10,
0.30, 0.40, and 0.50% HA (Jusoh et al., 2015). In our bone
TME platform, HA particles are distributed homogenously
within a fibrin gel and can be readily observed. We
confirmed that at ≥0.5% HA, the fibrin-HA mixture does
not polymerize in the microfluidic channel (Jusoh et al.,
2015). Therefore, we used fibrin/HA concentrations of 0.0, 0.2,
and 0.4%.
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A scanning electron microscopy (SEM) image of the
HA/fibrin composite containing 0.0, 0.2, and 0.4% HA is shown
in Figure 2A. As the concentration of HA increased, the locations
showing agglomeration thereof within the HA/fibrin composite
also increased. Additionally, while the fibrin gel had a relatively
uniform inter-fiber pore size, the pore size of the HA/fibrin
composite was distributed non-homogeneously. Moreover, the
composites with higher concentrations of HA were characterized
by larger gaps between agglomerated HA nanocomposites. In
contrast, as the concentration of HA increased, the number
of gaps between agglomerated HA nanocomposites decreased,
because the total amount of agglomerated HA nanoparticles
increased to fill the gaps. Furthermore, when the HA/fibrin
composite was prepared in six-well plates (Figure S1A), the
time required for it to solidify increased with increasing HA
concentration (Figure S1B).
Mechanical Properties of the HA/Fibrin
Composite
The mechanical properties (including the storage and loss
moduli, as determined by gel rheology under strain sweep
conditions) of the HA/fibrin composites with varying
concentrations of HA are shown in Figure 2B, Figure S2.
The critical strain (γc) was defined as the strain above which the
storage modulus decreased by more than 10% of the maximum
value of the storage modulus (Mancini et al., 2002). The critical
strain value of the fibrin gel was significantly lower at 0.2% HA
(γc = 1.94) compared to 0.0% HA (γc = 2.60). In contrast, the
critical strain was lower at 0.4% HA (γc = 3.66) compared to
0.2% HA. In addition, under 5% oscillation strain, the storage
modulus was lower at 0.2% HA (G’ = 122 Pa) compared to 0.0%
HA (G’ = 166 Pa), but was higher at 0.4% HA (G’ = 174 Pa)
compared to 0.2% HA.
Previous studies have addressed the relationship between
tissue morphology/response and the mechanical properties of
the gel composite (Rao et al., 2012, 2014). As noted above, the
HA/fibrin composite was subjected to varying strain waves in
gel rheology testing to analyze the critical strain (γc), which
represents the strain zone in which the modulus deviates from
linear behavior. Both the critical strain and the storage/loss
modulus at 5% oscillation strain were lower at 0.2% HA
compared to the conditioned fibrin gel, but higher at 0.4%
HA (Figure S3). Therefore, the mechanical properties of the
HA/fibrin composite were affected by the quantity of HA,
possibly due to effect on the morphology and architecture of
the matrix.
An HA/Fibrin Composite for Recapitulation
of the TME
The microfluidic device consisted of five parallel channels
separated by 100-µm gaps. To prevent leakage and to capture
the hydrogels, microposts were used in the microfluidic
device (Figure 1). By keeping HA nanoparticles in the fibrin
ECM, this platform allows detailed analysis of the HA-TME
interaction, which modulates cellular activity (Figure 1). Note
that an ideal platform for engineering bone-mimetic ECM
should have suitable 3D structures with interconnected pores to
facilitate cellular activities, while also supporting cell adhesion,
proliferation, and differentiation (Shamloo and Heilshorn, 2010).
As a scaffolding biomaterial, collagen-hydroxyapatite
composite scaffold was characterized for bone tissue engineering
(Rodrigues et al., 2003). Fibrin also has been widely known
as a biopolymer to emulate the natural nanostructured
features of bone and be favorable to precisely control its
nano/microstructure (Noori et al., 2017). Since collagen
demonstrates similar characteristics to fibrin in terms of fiber
thicknesses, the level of the total serum protein adsorption,
and bone regenerative response, both biomaterials have been
frequently used in bone tissue engineering (Oh et al., 2014).
Thus, a plethora of studies in bone tissue engineering are
conducted using both collagen and fibrin composites.
Tumor Cell Viability, Proliferation, and
Morphology
SW620 and MKN74 cells were incubated in a HA/fibrin
composite with 0.0, 0.2, or 0.4% HA for 1, 3, or 7 days
(Figures S4–S9, Figure 3). Cell viability was quantified by
live/dead assay, proliferation was assessed by Ki-67 staining,
and cell morphology was analyzed by determining the
cytoplasmic volume per cell by filamentous actin (F-actin)
staining (Figures S4–S9). We patterned tumor cells with 0.0,
0.2, and 0.4% HA/fibrin composite into the middle channel,
and injected fibroblasts into the two side channels to facilitate
paracrine interactions between the tumor cells and stromal cells.
MKN74 cells exhibited consistent viability during culture
in 0.0, 0.2, and 0.4% HA/fibrin composites (Figures 3B,C,
Figures S4, S5). The viability of SW620 cells at days 1 and
3 did not differ significantly according to HA concentration
(Figure 3C). However, at day 7, the viability of SW620 cells
cultured in 0.2 and 0.4% HA was significantly decreased
compared to those in 0.0% HA. In two-dimensional (2D)
culture, the viability of SW620 cells was not significantly
different, but that of MKN74 cells decreased with increasing HA
concentration (Figure S5). The proliferation rate (number of Ki-
67 positive cells) of both cell types decreased significantly over
time (Figures 3D,E, Figures S6, S7). Interestingly, the number
of Ki-67–positive MKN74 cells cultured in 0.4% HA at day 7
was significantly lower than in the control (Figure 3D). The
proliferation rate of SW620 cells cultured in 0.4% HA was
significantly lower than that of cells cultured in 0.0%HA at day 1,
but the opposite trend was evident at day 7 (Figure 3E). In 2D
culture, there was no significant difference in the proliferation
rate of MKN74 cells, but the proliferation rate of SW620 cells
cultured in 0.4% HA was markedly lower than that of the control
(Figure S7). The cytoplasmic volume per cell of MKN74, but not
SW620 cells, decreased over time (Figures 3F,G, Figures S8, S9).
The cytoplasmic volume per cell of MKN74 cells decreased with
increasing HA concentration at days 3 and 7, and did that of
SW620 cells at day 3 (Figures 3F,G). Interestingly, SW620 cells
with 0.4% HA showed a biphasic effect on cytoplasmic volume
per cell with increasing culture time (Figure 3G). However, in
2D culture, the cytoplasmic volume per cell of both cell types was
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FIGURE 2 | (A) SEM images of HA/fibrin composite with varying concentration of HA component (0.0, 0.2, and 0.4%). (Scale bar: 2µm). Yellow arrows indicate
agglomerated locations. (B) The storage and loss modulus as a function of strain at the same temperature and oscillation frequency in gel rheology analysis, indicating
critical strain for each plot.
unaffected by theHA concentration (Figure S9). Thus, tumor cell
proliferation and cytoplasmic volume per cell differed according
to the HA concentration in the HA/fibrin composite, and by time,
but the trends varied between the two cell lines.
HA components do not significantly affect cell viability,
enabling their clinical application; e.g., as doxorubicin-loaded
HA-coated nanoparticles in drug delivery systems for targeted
cancer therapy (Abbasi Aval et al., 2016). In this study, the
viability of SW620 (days 1 and 3) and MKN74 (days 1,
3, and 7) cells remained high in the HA/fibrin bone-like
matrix irrespective of the HA concentration, but the viability
of SW620 cells at day 7 with a high HA concentration
significantly decreased compared to the control, suggesting an
anti-tumor effect of HA. Therefore, HA affects cell viability in
a manner dependent on the cell type and culture duration. The
cytoplasmic volume of both SW620 and MKN74 cells tended
to decrease with increasing culture duration irrespective of
the HA concentration (Figures 3F,G). The cytoplasmic volume
of MKN74 tumor cells tended to decrease with increasing
HA concentration at days 3 and 7, but not SW620 cells,
likely due to the increased agglomerated locations, which
might hinder the volumetric growth of the cytoplasm in
tumor cells.
The cancer stroma plays roles in cancer at multiple stages.
Indeed, tumor cells do not act in isolation, but rather subsist in
an abundant microenvironment nourished by resident stromal
cells (e.g., fibroblasts and ECs) and the ECM. The tumor stroma
is essential for cancer initiation, growth, and progression (Pietras
and Ostman, 2010). In a previous study, fibroblasts induced
remarkable morphological changes in SW620 and MKN74 cells
within 48 h. Both cell types exhibited a significant increase in
cytoplasmic volume and clustered nuclei, possibly due to factors
secreted by the fibroblasts. In addition, studies involving co-
injection of tumor cells and mesenchymal cells from different
sources have demonstrated the importance of stromal fibroblasts
for tumor initiation, growth, and metastasis (Camps et al., 1990;
Karnoub et al., 2007).
HA exerts an anti-proliferation effect, possibly by inducing
apoptosis in certain types of cancer cells. HA nanoparticles
inhibit proliferation and induce apoptosis by producing
intracellular reactive oxygen species and activating p53, which
is responsible for DNA damage and apoptosis (Liu et al., 2003;
Chen et al., 2007; Alépée et al., 2010; Meena et al., 2012; Dey et al.,
2014), and smaller nanoparticles have a stronger anti-cancer
effect (Alépée et al., 2010; Meena et al., 2012; Dey et al., 2014).
Interestingly, the inhibitory effects of HA nanoparticles may be
cell type-specific, as the inhibitory effect of HA is greater for
cancer cells than for normal cells (Han et al., 2014). Consistent
with previous research, the proliferation rate of MKN74 cells
tended to decrease with increasing HA concentration in this
study. In contrast, at day 7, the number of Ki-67–expressing
SW620 cells increased with increasing HA concentration; the
opposite trend was detected at day 1. Therefore, some types
of cancer cell might alter their proliferation in response to
culture duration and HA concentration. Also, the correlations
of the viability, morphology, and proliferation of tumor cells
in the TME with HA concentration can be analyzed using
our platform.
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FIGURE 3 | Cancer cellular response assay in the HA/fibrin composite in the
microfluidic platform (A) Schematic representation of assay to observe cellular
responses of cancer cells cultured in the HA/fibrin composite in TME
co-cultured with fibroblasts. Representative confocal images of viability,
proliferation, and morphology of cancer cells. Quantification of assay for (C,D)
viability, (D,E) proliferation, (F,G) morphology conducted in the microfluidic
chip in different HA concentration and culture time points. (B,D,F: MKN 74,
and C,E,G: SW620, n = 4–6 chips per condition) The representative confocal
Images are demonstrated in Figures S4, S6, S8, respectively.
Tumor Cell Migration Within the
HA/Fibrin Composite
To evaluate migration of tumor cells through a bone-mimicking
matrix, we performed immunostaining for F-actin and confocal
microscopy to assess cell morphology (Figure 4). We first
attached two types of cancer cells to the side of the middle
FIGURE 4 | Cancer cell migration in HA/fibrin composite in the microfluidic
platform. (A) Schematic representation of assay to observe migration of
cancer cells cultured in the HA/fibrin composite in TME co-cultured with
fibroblasts. Confocal images and graphs for the number of invaded cancer
cells and invasion area per ROI for (B–D) MKN74, and (E–G) SW620
respectively in HA/fibrin composite with varying HA concentration (0.0, 0.2,
and 0.4%) (n = 5–9 chips per condition) (white arrows indicate nuclei of
migrated tumor cell into tunable bone mimicking ECM). (Scale bar: 100µm).
channel, which contained acellular fibrin gel, and stromal cells
plus fibrin gel were patterned in other microchannels to enable
paracrine interactions between cancer and stromal cells.
Figures 4C,D,F,G shows quantitative data on the cell invasion
of composites consisting of 0.0, 0.2, and 0.4% HA. The HA/fibrin
gel construct remained intact under various medium and culture
duration conditions (Figure S10).
Generally, the number of invaded cells decreased with
increasing HA concentration. In the HA/fibrin composites with
0.0% and 0.2% HA, 11 ± 2 and 6 ± 2 MKN74 cells, respectively,
had migrated, fewer than 30 ± 4 and 8 ± 3 SW620 cells,
respectively. However, at 0.4% HA, 4 ± 1 MKN74 cells had
migrated, compared to 2± 1 SW620 cells (Figures 4D,G).
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In addition, we quantified the invasion area based on the
actin cytoskele-ton. In general, the invasion area of both types
of cancer cell decreased with increasing HA concentration.
MKN74 cells had a significantly larger invasion area compared
to SW620 cells at all HA concentrations tested. For SW620
cells, the invasion area was 2,812 ± 171, 1,344 ± 188, and
244 ± 96 µm2 at 0.0, 0.2, and 0.4% HA, respectively. For
MKN74 cells, the invasion area was 8,212 ± 403, 3,959 ± 792,
and 3,305 ± 506 µm2, respectively. Therefore, MKN74 cells
exhibited enhanced actin filament formation in the HA/fibrin
matrix, despite their less marked migration than SW620
cells (Figures 4C,F).
Cancer progression is regulated by the interaction between
tumor cells and the stromal compartment, which consists of
stromal cells, ECM, chemokines, and blood vessels (Yamaguchi
and Condeelis, 2007). Therefore, cells must degrade and remodel
ECM structures to migrate through the ECM (Yamaguchi and
Condeelis, 2007). Despite its fertile environment, only certain
types of cancer cell preferentially spread to bone (Yoneda and
Hiraga, 2005). Therefore, cancer cells with a high predilection
for disseminating to bone may have biological properties
different from those of cancer cells that rarely spread to bone
(Ramaswamy et al., 2002).
FIGURE 5 | Angiogenesis induced by paracrine signaling from TME
co-cultured with cancer cells and fibroblasts in HA/fibrin composite in the
microfluidic platform. (A) Schematic representation of angiogenesis in fibrin
gel, which was induced TME consisting of cancer cells and fibroblasts in
bone-mimicking matrix. Confocal image and graph for sprouting length of
blood vessels for (B,C) MKN74 and (D,E) SW620 respectively in HA/fibrin
composite with varying HA concentration (0.0, 0.2, and 0.4%). (n = 5–9 chips
per condition). (Scale bar: 100µm).
FIGURE 6 | Reconstitution of vascularized three-dimensional tumor-stromal
cell spheroid in HA/fibrin composite in the microfluidic platform. (A) Schematic
representation of assay to observe angiogenesis with three-dimensional tumor
spheroid in HA/fibrin composite. Confocal images and graph for the number of
blood vessel sprouts and sprouting length of blood vessels for (B–D) MKN74
and (E–G) SW620 respectively in HA/fibrin composite with varying HA
concentration (0.0, 0.2, and 0.4%) (n = 5–7 chips per condition). (Scale bar:
200µm).
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It is important to note that both SW620 and MKN74
cells exhibited significantly reduced migration at higher HA
concentrations. This was likely because of the increased quantity
of agglomerated regions in the microstructure of the HA/fibrin
composite, which inhibit cellular movement. These results are in
agreement with those of the cytoplasmic volume per cell.
Angiogenesis Induced by Paracrine
Signaling From TME in the
HA/Fibrin Composite
To evaluate TME-induced angiogenesis in the microfluidic
platform, cancer cells were incubated with fibroblasts to
recapitulate the TME before introducing ECs. Cancer cells and
fibroblasts were co-cultured within the HA/fibrin matrix and
TME induced-angiogenesis was evaluated (Figure 5A). In our
platform, the opening between the posts at the interface of the
central channel facilitates paracrine interactions between ECs
and cancer/stromal cells during vessel formation. To this end,
an acellular fibrin gel was patterned into the middle channel and
ECs were attached to the fibrin walls of the middle channel. In
general, incubation of MKN74 and SW620 cells with fibroblasts
in the HA/fibrin composite reduced angiogenesis, as the sprout
length decreased with increasing HA concentration. For MKN74
cells, the sprout length was 445 ± 69, 337 ± 49, and 246 ±
56µm at 0.0, 0.2, and 0.4% HA, respectively (Figures 5B,C). For
SW620 cells, the sprout length was 393 ± 50, 300 ± 37, and 237
± 40µm at 0.0, 0.2, and 0.4% HA, respectively (Figures 5D,E).
Thus, paracrine signals from tumor and stromal cells in the
HA/fibrin composite with a high HA concentration resulted in
the formation of fewer sprouts.
The metabolic and nutritional needs for tumor growth and
metastasis are met by the formation of a complex angiogenesis
vascular network (Alépée et al., 2010; Weis and Cheresh, 2011).
Therefore, controlling tumor-associated angiogenesis shows
promise for limiting cancer progression (Weis and Cheresh,
2011). In vivo, the TME consists of a variety of cell types
and numerous signaling molecules and pathways that influence
angiogenesis. In addition, tumor cells in the TME activate the
surrounding normal cells by releasing cytokines, growth factors,
guidance molecules, andmatrix metalloproteinases (Alépée et al.,
2010; Weis and Cheresh, 2011).
Angiogenesis results from stimulatory signals within the
TME that prompt changes in multiple cell types (Weis and
Cheresh, 2011). Growth factors and cytokines secreted by tumor
cells promote angiogenesis from a nearby vessel for invasion,
before intravasating within the local vasculature and, prior to
extravasating by adhering to the vessel wall, transmigrating across
the endothelium and invading the ECM (Katt et al., 2016). For
example, during angiogenesis, vascular endothelial growth factor
(VEGF) stimulates the sprouting and proliferation of ECs to form
blood vessels (Weis and Cheresh, 2011). By using our platform
to enable intercellular communication via secreted factors, we
determined that addition of HA to co-cultures of cancer cells and
stromal fibroblasts induced secretion of factors that suppressed
angiogenesis. Thus, we assayed the concentrations of VEGF,
tumor necrosis factor-alpha (TNF-α), and transforming growth
factor-beta (TGF-ß) using enzyme-linked immunosorbent assays
(Figure S11). The concentrations of these factors differed slightly
according to HA concentration. Elucidation of the angiogenic
sprouting mechanism may lead to the development of effective
therapeutics against angiogenesis in the bonemicroenvironment.
Reconstitution of Vascularized Tumor
Spheroids in the HA/Fibrin Composite
To demonstrate crosstalk between the tumor and the TME,
we patterned tumor-fibroblast microspheroids into the center
channel using HA/fibrin composites comprising 0.0, 0.2,
and 0.4% HA (Figure 6). Attached ECs exhibited angiogenic
sprouting in response to the microenvironment generated
by interactions between SW620- and MKN74-fibroblast
microspheroids (Figures 6B,E). For both MKN74 and SW620
cells, the number of angiogenic sprouts decreased with
increasing HA concentration (Figures 6C,F). In contrast,
sprout length showed a biphasic response to an increasing HA
concentration (Figures 6D,G). For MKN74 cells, the sprout
length in the 0.2% HA/fibrin composite (656.3 ± 112.6µm)
was dramatically greater compared to the control (450.8 ±
122.4µm), but did not differ significantly between 0.0% and
0.4% HA. For SW620 cells, the sprout length of the 0.4%
HA/fibrin composite (363.9 ± 84.1µm) was significantly
smaller compared to the control (531.1 ± 115.6µm), and
there was no significant difference between 0.0 and 0.2% HA.
The new blood vessels physically interacted with the tumor
spheroids while migrating through ECM containing bone
mineral components, indicating TME-induced angiogenesis
(Figures S13, S14, Supplementary Video S1). Interestingly,
at 0.4% HA, both MKN74-fibroblast and SW620-fibroblast
microspheroid-induced angiogenesis was markedly reduced
compared to 0.0% and 0.2% HA, suggesting an anti-angiogenic
effect. Importantly, the angiogenesis induced by SW620-
fibroblast microspheroids resulted in thinner blood vessels
than that promoted by MKN74-fibroblast microspheroids,
demonstrating the molecular and cellular heterogeneity of the
TME induced angiogenesis.
Within bone environment, cells are steadily encounter
physical forces such as hydrostatic pressure, shear, compression
and tension. Piezoelectric bone microenvironment can
generate electrical signals in response to the mechanical
stress (Ribeiro et al., 2015; Hytönen and Wehrle-Haller,
2016; Jacob et al., 2018). These cellular functions involving
mechanical interaction are amenable to be modulated by
mechanosensitive Piezo channels that transduce mechanical
stimuli into intracellular signals (Coste et al., 2010). The
balance between mechanical stress and cellular reaction is
crucial to sustain tissue homeostasis and, in consequence of
loss of the equilibrium leads to pathology including cancer
(Michor et al., 2011). Indeed, functional expression of Piezo
channels has been demonstrated in malignant breast cancer
cell lines (Li et al., 2015). Piezo1 senses rigidity changes in the
environment and optimizes confined cell migration (Hung
et al., 2016). In addition, Piezo1 served as sensor of shear
stress and determinants of vascular structure (Li et al., 2014).
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Piezo2 is essential to metastatic cancer cells to probe their
physical environment as they anchor and pull on their
surroundings (Pardo-Pastor et al., 2018). The Piezo2-induced
Ca2+ signal activates downstream the RhoA-mDia pathway
necessary for the regulation of cancer metastasis (Pardo-
Pastor et al., 2018). Although in this study focused on
the reconstituting of bone-mimicking TME in response to
tunable HA concentration, the ability to robustly pattern with
multifarious approach could be applied to broad bone TME
application including mechanotransduction.
Our platform enables recapitulation of 3D vascularized tumor
spheroids in a TME consisting of ECM and minerals. Three-
dimensional spheroids comprising tumor fibroblasts formed
by aggregation and exhibited protein and mRNA profiles that
resembled those in vivo (Kloss et al., 2008; Friedrich et al., 2009;
Katt et al., 2016). Additionally, the 3D spheroids recapitulated
the cell-cell and cell-matrix interactions between tumor cells
and the 3D TME (Mehta et al., 2012). Tumor spheroids induce
vascularization, which requires a vascular network to deliver
oxygen and nutrients (Mueller-Klieser, 1987; Friedrich et al.,
2009). In particular, in a bone-like microstructure, the stiffness
of the ECM modulates capillary formation and barrier integrity
by altering the endothelial response to chemical factors (LaValley
and Reinhart-King, 2014).
In TME, pericytes are also capable of tumor homing and
crucial stromal cellular components of TME. However, our
current system lacked pericytes (von Tell et al., 2006; Ahn
et al., 2018b). Therefore, fully mimicking the tumor-stromal
interactions in complex bone TMEs remains a challenge.
CONCLUSION
As a proof of concept study, we reconstructed the TME in a
mineralized microstructure by incorporating highly metastatic
SW620 andMKN74 cells within a microfluidic platform.We also
investigated the relationship between the mechanical properties
and cellular activities of the bone-mimicking ECM. The viability,
morphology, and proliferation of both types of cancer cells in the
HA/fibrin composite varied according to the HA concentration
and culture duration. Moreover, both SW620 and MKN74
cells demonstrated significantly reduced migration at higher
HA concentrations. Also, angiogenic sprouts induced by TME
paracrine signaling tended to be shorter when ECs were cultured
in an HA-rich TME embedded composite. Furthermore, during
angiogenesis in tumor-stromal cell spheroids in the HA/fibrin
composite, the number of blood vessel sprouts decreased as the
HA concentration increased, while the sprout length exhibited
a biphasic response to an increasing HA concentration. In
conclusion, we established an in vitro bone-mimetic TME model
within tunable mineralized microstructure, and used it to assess
the influence of stromal cells on tumor angiogenesis, migration,
and proliferation. The results will promote the development
of microfluidic platforms containing physiologically bone-
relevant mineralized structures, which will in turn facilitate drug
screening and mechanistic studies of tumor metastasis, growth,
and progression in an osseous ECM.
EXPERIMENTAL SECTION
Device Fabrication
Microfluidic device with the center channel of 800µm wide
was used in this study. The microfluidic chip were fabricated
by polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning)
mold embedded with channel structures that was patterned
by standard photolithography photoresist SU-8 (MicroChem).
Demolded PDMS was punched out by using a biopsy punch
(6mm) and sharpened syringe needle (0.5mm) to make
reservoirs for the medium and hydrogel injection ports. A PDMS
device and a glass coverslip was treated with oxygen plasma
for 1min before bringing them into contact. The devices were
incubated in an 80◦C dry oven for at least 48 h to restore
hydrophobicity of PDMS. The devices were sterilized by UV
irradiation before use.
HA/fibrin Composite Preparation
Hydroxyapatite nanocrystals with sizes <200 nm.
Hydroxyapatite in EGM-2 media were sonicated for 40min
for particles dilution. The pure fibrin matrix (0.0% HA) was
prepared by dissolving 2.5 mg/ml bovine fibrinogen (Sigma)
in PBS (Gibco) and supplemented with aprotinin (0.15 U/ml,
Sigma) prior mixing with thrombin (0.5 U/ml, Sigma), before
left to clot at room temperature for 5min (Kim et al., 2013).
For HA/fibrin composite, the appropriate HA solution (0.0, 0.2,
and 0.4% HA) is mixed with the fibrinogen and aprotinin before
mixing with the thrombin.
Mechanical Properties Test
The mechanical properties of acellular HA/fibrin composite were
measured by rotational rheometer (TA instrument Ltd., DHR-1,
Delaware, USA) equipped with parallel plate (25mm diameter)
at a gap height of 1mm. The composite with 0, 0.2 and 0.4% HA,
respectively was placed on the plate of the rheometer. The storage
modulus (G’) and loss modulus (G”) were measured using strain
sweeping mode with frequency fixed at 1rad/s at 25◦C.
Scanning Electron Microscopy (SEM)
SEM was used as a tool for the observation of the microstructure
of HA/fibrin composite. SEM examination of the structure was
performed using critical point drying and platinum coating of
samples. The composites were first washed in PBS, then fixed in
a 2% glutaraldehyde solution for 1 h 30min. And the composites
were washed in 0.05M sodium cacodylate buffer for 10min and
the washing step is repeated washing step is repeated twice.
Fixation was followed by a dehydration series in 30, 50, 70, 80, 90,
100 (×3) ethanol solutions for 20min each. Dehydrated samples
were placed in a critical point dryer (Leica EM CP300, Germany)
and ethanol was replaced with CO2 and subsequently removed.
The dried samples were mounted on aluminum stubs, sputter-
coated with platinum, and examined by field emission scanning
electron microscopy (FE-SEM; HITACHI S-5000).
Cell Cultures
Human umbilical vein endothelial cells (HUVECs, Lonza) and
red fluorescent protein-expressing HUVECs (RFP-HUVECs)
(Angio-Proteomie) were cultured in endothelial basal medium-2
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(EBM-2, Lonza) supplemented with EGM-2 bullet kit and normal
human lung fibroblasts (LFs, Lonza) were cultured in fibroblast
basal medium (FBM-2, Lonza) supplemented with FGM-2 bullet
kit. All cancer cells were from Korean cell line bank (KCLB,
Korea). Human colon cancer (SW620) and human gastric cancer
(MKN74) were cultured in Dulbescco’s modified Eagle’s mideiun
(DMEM, Hyclone) supplemented with 10% fetal bovine serum
(FBS, Gibco), penicillin, and streptomycin (100 U/mL) (Sigma
Aldrich). All cells were incubated at 37◦C in a humidified 5%
CO2 atmosphere.
Tumor Cells Viability, Morphology and
Proliferation Assay
Human umbilical vein endothelial cells (HUVECs, Lonza) and
red fluorescent protein-expressing HUVECs (RFP-HUVECs)
(Angio-Proteomie) were cultured in endothelial basal medium-2
(EBM-2, Lonza) supplemented with EGM-2 bullet kit and normal
human lung fibroblasts (LFs, Lonza) were cultured in fibroblast
basal medium (FBM-2, Lonza) supplemented with FGM-2 bullet
kit. All cancer cells were from Korean cell line bank (KCLB,
Korea). Human colon cancer (SW620) and human gastric cancer
(MKN74) were cultured in Dulbescco’s modified Eagle’s mideiun
(DMEM, Hyclone) supplemented with 10% fetal bovine serum
(FBS, Gibco), penicillin, and streptomycin (100 U/mL) (Sigma
Aldrich). All cells were incubated at 37◦C in a humidified 5%
CO2 atmosphere.
For 2D assay, PDMS block was punched using 6mm biopsy
punch and pre-treated with 10µg/mL of fibronectin (Sigma)
for 2 h and washed 3 times before cancer cell seeding. Cancer
cells were seeded with 100 µL of the 1.5 × 104 cells/ml density
into each well. After 2 days of DMEM media culture, culture
media was changed into different contained media with different
concentration (0.0%, 0.2%, and 0.4%) and analyzed after 3 days
of culture.
Cancer Cells Migration Assay
Channels configuration is shown on Figure 4A. The upper
channel was injected with dissociated LFs (8× 106 cells/ml). The
center channel was filled with acellular HA/fibrin composite of
0.0%, 0.2%, and 0.4% HA, in the different devices. SW620 or
MKN74 cancer cells suspended in EGM-2 at a concentration of
10 × 106 cells/ml were introduced at the boundary of center
channel. The microfluidic chip was tilted by 90 degrees for
30min for adhering the tumor cells onto theHA/fibrin composite
surface. The devices were filled with EGM-2 media and cells were
incubated at 37◦C in a humidified 5% CO2 atmosphere for 5
days. Number of migrated tumor cells and invasion area were
evaluated using ImageJ with the Fiji plugin.
Angiogenesis Induced by Paracrine
Signaling From TME Assay
Channels configuration is shown on Figure 5A. The upper
channel were injected with the mixture of HA/fibrin composite
(0.0, 0.2, and 0.4% HA), LFs (8 × 106 cells/ml) and SW620
or MKN74 (8 × 106 cells/ml). Briefly, dissociated LFs and
SW620 or MKN74 cells in EGM-2 media were mixed at 1:1
volume ratio, before mixing with HA/fibrin. The device was
incubated for 24 h at 37◦C and 5% CO2 to dissipate the air
bubbles and to establish the tumor microenvironment within
the mineralized matrix by interaction between tumor cells with
fibroblasts. Angiogenesis cell seeding was conducted based on the
established procedure (Kim et al., 2013). HUVECs suspended in
EGM-2 at a concentration of 8 × 106 cells/ml were introduced
at the boundary of center channel. The microfluidic chip was
tilted by 90 degrees for 30min for adhering the HUVECs onto
surface of the central fibrin gel. The devices were filled with EGM-
2media and cells were incubated at 37◦C in a humidified 5%CO2
atmosphere. The tumormicroenvironment induced angiogenesis
assay was conducted for 5 days. Angiogenesis sprouting length
was determined using ImageJ with the Fiji plugin.
Vascularized Three-Dimensional Tumor
Spheroid in the HA/Fibrin Composite
Channels configuration is shown on Figure 6A. The upper
channel injected with LFs (4 × 106 cells/ml) and fibrin matrix.
Three-dimensional SW620 and MKN74 spheroids with LF were
prepared using SpheroFilm (INCYTO) (Figure S12). In detail,
each SW620 and MKN74 suspension cells (5 × 105 cells/ml;
3.5ml per 60 mm2 dish) were mixed with trypsinized LF (5 ×
105 cells/ml; 3.5ml per 60 mm2 dish) at 1:1 ratio and cultured in
EGM-2 medium. After 2 days, the media in the dish changed and
the spheroids were cultured for 4 days. After 4 days, the spheroids
were collected using cell strainer and were mixed with HA/fibrin
composite (0.0, 0.2, and 0.4% HA). Angiogenesis cell seeding was
conducted based on the established procedure (Kim et al., 2013).
HUVECs suspended in EGM-2 at a concentration of 8 × 106
cells/ml were introduced at the boundary of center channel. The
microfluidic chip was tilted by 90 degrees for 30min for adhering
the HUVECs onto the HA/fibrin composite surface. The devices
were filled with EGM-2 media and cells were incubated at 37◦C
in a humidified 5% CO2 atmosphere. 3D tumor microspheroid
with angiogenesis was conducted for 5 days. Number of sprouts




Twenty-foury transwells were used formedium for further ELISA
analysis. The transwell were loaded with themixture of HA/fibrin
composite (0.0, 0.2, and 0.4% HA), LFs (8 × 106 cells/ml) and
SW620 orMKN74 (8× 106 cells/ml). Briefly, dissociated LFs and
SW620 or MKN74 in DMEM media were mixed at 1:1 volume
ratio, before mixing with HA/fibrin composite prior to loading
into the transwell. The transwells were filled with EGM-2 media
and were incubated at 37◦C in a humidified 5% CO2 atmosphere.
After 3 days, the medium from each device was collected for
ELISA analysis base on standard procedure (Chung et al., 2017).
Immunostaining and Imaging
For immunostaining, cell samples were prepared followed
the standard procedure. The samples were fixed with 4%
(v/v) paraformaldehyde in PBS for 10min, followed by
permeabilization for 15min with a 0.2% Triton X-100 (Sigma)
solution and 1htreatment of 3% bovine serum albumin (BSA,
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 10 July 2019 | Volume 7 | Article 168
Ahn et al. Bone-Mimetic Tumor Microenvironment
Sigma). The samples were stained and incubated at least
overnight at 4◦C with respective primary antibody as required
before stained with Hoechst 33342 (1:1,000) for 1 h of incubation
at room temperature on the next day. F-actin, Phalloidin (Alexa
Fluor 488) with dilution 1:150 was used. The samples were
washed three times and stored in PBS before imaging. For
cross-section and whole-construct imaging of 3D blood vessels,
stained samples were examined using a FluoView FV1000
confocal laser scanning unit with the IX81 inverted microscope
(Olympus). Confocal images were processed by IMARIS
software (Bitplane).
Statistical Analysis
Prism (GraphPad, USA) was used for one-way ANOVA analysis
with Tukey’s post-test. ∗∗∗ denotes p < 0.001, ∗∗ denotes
0.001< p <0.01, ∗ denotes 0.01 < p < 0.05. For significant
testing between two conditions non-paired student’s t-test
as used. All data were expressed as the mean ± standard
deviation (SD).
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